Similarly, ROS1 fusion is extremely rare in patients with small cell lung cancer (SCLC), and there is a notable absence of clinical trials or case reports documenting SCLC patients with ROS1 fusions. This evidence concerns the gene ROS1 and small cell lung carcinoma.